127 related articles for article (PubMed ID: 15870888)
1. Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.
Loberg RD; Neeley CK; Adam-Day LL; Fridman Y; St John LN; Nixdorf S; Jackson P; Kalikin LM; Pienta KJ
Int J Oncol; 2005 Jun; 26(6):1699-705. PubMed ID: 15870888
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein.
Lin J; Liu J; Wang Y; Zhu J; Zhou K; Smith N; Zhan X
Oncogene; 2005 Mar; 24(12):2059-66. PubMed ID: 15688017
[TBL] [Abstract][Full Text] [Related]
3. MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta.
Woodings JA; Sharp SJ; Machesky LM
Biochem J; 2003 Apr; 371(Pt 2):463-71. PubMed ID: 12570871
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
De Ganck A; De Corte V; Bruyneel E; Bracke M; Vandekerckhove J; Gettemans J
Int J Oncol; 2009 May; 34(5):1403-9. PubMed ID: 19360353
[TBL] [Abstract][Full Text] [Related]
5. Missing-in-metastasis MIM/MTSS1 promotes actin assembly at intercellular junctions and is required for integrity of kidney epithelia.
Saarikangas J; Mattila PK; Varjosalo M; Bovellan M; Hakanen J; Calzada-Wack J; Tost M; Jennen L; Rathkolb B; Hans W; Horsch M; Hyvönen ME; Perälä N; Fuchs H; Gailus-Durner V; Esposito I; Wolf E; de Angelis MH; Frilander MJ; Savilahti H; Sariola H; Sainio K; Lehtonen S; Taipale J; Salminen M; Lappalainen P
J Cell Sci; 2011 Apr; 124(Pt 8):1245-55. PubMed ID: 21406566
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.
Nixdorf S; Grimm MO; Loberg R; Marreiros A; Russell PJ; Pienta KJ; Jackson P
Cancer Lett; 2004 Nov; 215(2):209-20. PubMed ID: 15488640
[TBL] [Abstract][Full Text] [Related]
7. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA
Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas.
Wang Y; Liu J; Smith E; Zhou K; Liao J; Yang GY; Tan M; Zhan X
Cancer Invest; 2007 Mar; 25(2):79-86. PubMed ID: 17453818
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer.
Hayes NV; Blackburn E; Smart LV; Boyle MM; Russell GA; Frost TM; Morgan BJ; Baines AJ; Gullick WJ
Clin Cancer Res; 2007 Jun; 13(11):3147-55. PubMed ID: 17545517
[TBL] [Abstract][Full Text] [Related]
10. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.
Prasad PD; Stanton JA; Assinder SJ
Cell Tissue Res; 2010 Feb; 339(2):337-47. PubMed ID: 20012321
[TBL] [Abstract][Full Text] [Related]
11. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
12. ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.
Zhang JS; Gong A; Young CY
Oncogene; 2007 Jan; 26(1):111-22. PubMed ID: 16799630
[TBL] [Abstract][Full Text] [Related]
13. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
Reyes I; Tiwari R; Geliebter J; Reyes N
Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
[TBL] [Abstract][Full Text] [Related]
14. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.
Korkmaz CG; Korkmaz KS; Kurys P; Elbi C; Wang L; Klokk TI; Hammarstrom C; Troen G; Svindland A; Hager GL; Saatcioglu F
Oncogene; 2005 Jul; 24(31):4934-45. PubMed ID: 15897894
[TBL] [Abstract][Full Text] [Related]
16. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
19. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
20. Verprolin function in endocytosis and actin organization. Roles of the Las17p (yeast WASP)-binding domain and a novel C-terminal actin-binding domain.
Thanabalu T; Rajmohan R; Meng L; Ren G; Vajjhala PR; Munn AL
FEBS J; 2007 Aug; 274(16):4103-25. PubMed ID: 17635585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
